Proskauer’s multidisciplinary Life Sciences Group combines deep industry knowledge with technical and regulatory expertise, transactional strength, and seasoned dispute resolution capabilities. We bring together decades of experience across a wide range of transaction structures, disputes, therapeutic areas and stages of the life sciences business and product life cycle – for product sponsors, investors, and collaboration partners. We counsel businesses on developing robust offensive and defensive patent portfolios, analyzing freedom-to-operate, structuring clinical trials, filling pipelines and spinning off technologies, executing a wide range of commercial, strategic and financing transactions, raising capital and navigating the health care and FDA regulatory landscape. We have a proven track record of success resolving bet-the-company antitrust, intellectual property and commercial disputes, and guiding clients through significant federal regulatory interactions. Our integrated approach allows us to provide comprehensive, seamless service to clients around the globe.

Our Life Sciences Group delivers advice that is both strategic and practical across disciplines, borders and stages of growth. We represent public and private pharmaceutical, biotechnology and medical technology companies, as well as private equity sponsors, private credit lenders, private investment funds, asset managers and other investors, academic medical centers, research institutions, CROs, CDMOs/CMOs and other strategic partners that power the industry. Whether a client is forming a company, raising or deploying capital, designing IP strategy, structuring an acquisition, license or research collaboration, preparing for clinical trials or commercialization, scaling manufacturing or protecting a core asset in litigation, Proskauer provides industry-calibrated counsel aligned with business goals.